IL22 and non-small cell lung carcinoma: Meanwhile, overexpression of IL22 protects NSCLC cancer cell lines from chemotherapy-induced apoptosis via activation of STAT3, which triggers the expression of downstream anti-apoptotic proteins including BCL2 and BCL-xL [196].